ArticleThe Gerontologist2025
Placing public health onto the Alzheimer's disease and related dementias public policy platform.
Article in The Gerontologist, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
In 2017, the United States Senate Special Committee on Aging added public health to the Alzheimer's disease and related dementias (ADRD) policy platform by introducing the Building Our Largest Dementia Infrastructure for Alzheimer's Act. Since then, 34 state health departments, 7 local, 2 territorial, and 1 tribal health organization have received a BOLD Program award from the Centers for Disease Control. With the support of the Alzheimer's Association and university-based Centers of Excellence, their efforts have increased public awareness, expanded training of health-care providers, linked public health programs and health-care systems, and supported programs to reduce the risk for ADRD. In this forum, we draw on examples of federal and state policymaking targeting persons living with dementia and demonstrate how iron triangles consisting of advocacy organizations, public servants and policymakers have been critical in building a public policy platform for more than 50 years. We then consider how public health leadership may rely on such iron triangles to expand their role, focusing on the critical role assumed by professional and academic organizations in educating and training those who may help respond to the public health crisis being presented by the booming number of older Americans with ADRD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.